000 | 00971 a2200265 4500 | ||
---|---|---|---|
005 | 20250513120347.0 | ||
264 | 0 | _c19970529 | |
008 | 199705s 0 0 eng d | ||
022 | _a0003-4819 | ||
024 | 7 |
_a10.7326/0003-4819-126-11-199706010-00019 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBittar, G B | |
245 | 0 | 0 |
_aHypolipidemic drugs in coronary artery disease. _h[electronic resource] |
260 |
_bAnnals of internal medicine _cJun 1997 |
||
300 |
_a916-7 p. _bdigital |
||
500 | _aPublication Type: Comment; Letter | ||
650 | 0 | 4 |
_aCholesterol, LDL _xblood |
650 | 0 | 4 |
_aCoronary Disease _xblood |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHyperlipidemias _xprevention & control |
650 | 0 | 4 |
_aHypolipidemic Agents _xtherapeutic use |
773 | 0 |
_tAnnals of internal medicine _gvol. 126 _gno. 11 _gp. 916-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.7326/0003-4819-126-11-199706010-00019 _zAvailable from publisher's website |
999 |
_c9144508 _d9144508 |